Tris Pharma Announces Acceptance of Its First Two NDAs

Tris Pharma, a privately owned specialty pharmaceutical company that develops innovative drug delivery technologies, announced that the US Food and Drug Administration has accepted its first two New Drug Applications (NDAs) for once-daily formulations of a cardiovascular drug.
Sys-Con Media